AUSTIN, 20 NOVEMBER 2024: OriGen Biomedical is proud to announce that its President & CEO, Beth San Segundo, has been ranked #38 on the prestigious Women2Watch 2024 list, presented by the Women Presidents’ Organization (WPO) in partnership with JPMorgan Chase Commercial Banking. The Women2Watch list highlights the 50 fastest-growing women-led or women-owned companies that are members of the WPO. It includes various industries, such as healthcare, information technology, financial services, and human resources.
OriGen Biomedical has seen remarkable growth under Beth San Segundo’s leadership, driven by its commitment to quality and innovation in the field of cryopreservation and cell culture products. Beth’s dedication to fostering a supportive and forward-thinking workplace has played a key role in OriGen’s continued success.
Beth San Segundo shared her gratitude and excitement for this recognition, stating, “I am deeply honored to be recognized as a Women2Watch award recipient by the WPO and JPMorgan Chase. This recognition is a testament to my journey and the incredible team and mission fueling OriGen Biomedical’s success. I am privileged to lead an organization committed to improving patient outcomes and advancing healthcare globally. I hope this award inspires women everywhere to embrace their leadership potential and create meaningful change in their industries and communities.”
The Women Presidents’ Organization is a global nonprofit organization with over 2,000 women entrepreneurs from 10 countries. The Women2Watch list, now in its 17th year, celebrates businesses with exceptional growth rates, innovation, and the transformative leadership of their female executives. This year, the honorees collectively generated over $6.8 billion in combined revenue and employed more than 31,000 people.
To qualify for the ranking, businesses must have applied for the 2024 50 Fastest Growing Women-Owned / Led Companies™, be WPO members in good standing, privately held, woman-owned or -led, and must have reached annual revenues of at least $500,000 in each of the past five years. In addition, WPO members must run their company’s day-to-day management as the CEO/President/Partner, with at least $2 million in annual revenue ($1 million for service-based businesses).
ABOUT ORIGEN BIOMEDICAL
OriGen Biomedical, Inc. is a leading producer of cryopreservation and cell culture products. Our focus is to produce a range of products to support the treatment of cancer, genetic conditions, and other life-threatening diseases. OriGen Biomedical® products are designed with the patient and user in mind, and we strive to maintain excellent customer service to ensure that patient care is the priority. Quality is the foundation of all product designs at OriGen, and each product is produced with the intention that it will improve patient health. Founded in 1997 and headquartered in Austin, Texas, OriGen is certified annually to ISO 13485 standards and regularly inspected by the FDA, MDSAP, ISO certification organizations, and our customers. To learn more visit www.origen.com and follow us on LinkedIn and Twitter.
ABOUT WOMEN PRESIDENTS ORGANIZATION (WPO)
The Women Presidents Organization (WPO) is a non-profit membership organization where dynamic and diverse women business leaders around the world tap into collective insight with exclusive access to entrepreneurial equals, innovative ideas, and executive education. WPO members have guided their business to generate at least $2 million USD in gross annual sales (or $1 million USD for a service-based business). Each WPO chapter serves as a professionally facilitated peer advisory group for members where they can harness the momentum of their successes and cultivate new strategies that will take them even further. Learn more at www.women-presidents.com.
CONTACT:
Kirsten Krupps – Marketing Manager
OriGen Biomedical, Inc.
k.krupps@origenbio.com
512-474-7278
